Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer discovers soluble guanylate cyclase activators

July 4, 2022

New antibacterials described by the Centre National de la Recherche Scientifique (CNRS)

July 4, 2022

FKBP51 blockade ameliorates cognitive function during obesity

July 4, 2022

ENT1 inhibitor reverses sporadic Alzheimer's disease in mice

July 1, 2022

Sutro Biopharma generates hemiasterlin/TLR agonist dual-conjugate anti-FolR-alpha ADCs

July 1, 2022

Anti-alpha-1-antitrypsin BMN-349 reverses liver disease in a preclinical model

July 1, 2022

China NMPA approves IND for Henlius' anti-TIGIT Fc fusion protein HLX-53

July 1, 2022

Ildong licenses Twist VHH antibody libraries for antibody discovery in immuno-oncology

July 1, 2022

Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases

July 1, 2022

CSF1R inhibition could delay muscular dystrophy progression

July 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...